InsiderTrades

Form 4 for ALDX Aldeyra Therapeutics, Inc.

Accepted 2023-09-11 00:00:00 ET · period of report 2023-09-07 · accession 0000950170-23-047530 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-09-11 2023-09-07 ALDX Brady Todd C Pres, CEO, Dir M - OptEx $0.55 +273.1K 1.68M +19% +$150.2K
D 2023-09-11 2023-09-07 ALDX Brady Todd C Pres, CEO, Dir F - Tax $7.22 -73.8K 1.65M -4% -$532.9K
DM 2023-09-11 2023-09-07 ALDX Brady Todd C Pres, CEO, Dir M - OptEx $0.00 -273.1K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-09-07 M A 192,084 $0.55 1,647,369 D — —
2 Common Common Stock 2023-09-07 F D 73,807 $7.22 1,654,536 D — — (F1) Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the exercise of the stock options.
3 Common Common Stock 2023-09-07 M A 48,021 $0.55 1,728,343 D — —
4 Common Common Stock 2023-09-07 M A 32,953 $0.55 1,680,322 D — —
5 Derivative Stock Option (right to buy) 2023-09-07 M D 48,021 $0.00 0 D $0.55 · — to 2023-09-07 48,021 Common Stock (F2) The stock option is fully vested.
6 Derivative Stock Option (right to buy) 2023-09-07 M D 192,084 $0.00 0 D $0.55 · — to 2023-09-07 192,084 Common Stock (F2) The stock option is fully vested.
7 Derivative Stock Option (right to buy) 2023-09-07 M D 32,953 $0.00 0 D $0.55 · — to 2023-09-07 32,953 Common Stock (F2) The stock option is fully vested.